Infliximab in chronic active Crohn's disease
Reading time: 2 minutes
A technology assessment report 1 on infliximab in chronic active Crohn's disease resistant to conventional treatment was abst...
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
{{branchArticle.articleDatabase.name}}
Article ID:{{branchArticle.id}}
{{branchArticle.publishedStr}}
Authors: {{branchArticle.authors}}
Copyright © Dental Mammoth. All Rights Reserved
Copyright © Duodecim Medical Publications Ltd. 2018. All Rights Reserved
Table of contents
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
Evidence Summaries
Article ID: evd04445
Published 27.02.2004
Authors: Editors
Copyright © Duodecim Medical Publications Ltd. All Rights Reserved
{{selectedMetadata.pluginDescription || selectedMetadata.metaId}}
{{metaDataError}}
|
|